{"chunk_type":"transcript_chunk","text":"ì´ ê°•ì˜ì˜ í•µì‹¬ì€ **\"Outside-In Approach\"**ì…ë‹ˆë‹¤. ê²‰ìœ¼ë¡œ ë³´ì´ëŠ” í”¼ë¶€ë‚˜ ì²™ì¶”ì˜ ì†Œê²¬ì´ ì•ˆìª½ì˜ ì‹ ê²½ê³„ ë¬¸ì œë¥¼ ë°˜ì˜í•œë‹¤ëŠ” ê²ƒì´ì£ ! (Embryology: Skin & Brain = Both Ectoderm origin ğŸ‘¯â€â™‚ï¸)\n---\n### ğŸŒ³ Top-Down Classification: Pediatric Neurology (Congenital)\nPlaintext\n`Pediatric Neurology (Congenital & Developmental)\nâ”‚\nâ”œâ”€â”€ 1. Neurocutaneous Disorders (Phakomatoses) ğŸ§¬\nâ”‚   â”œâ”€â”€ NF1 (Neurofibromatosis Type 1) - Skin & Bone\nâ”‚   â”œâ”€â”€ NF2 (Neurofibromatosis Type 2) - Ears & Eyes\nâ”‚   â”œâ”€â”€ Tuberous Sclerosis (TSC) - Multi-system Chaos\nâ”‚   â”œâ”€â”€ Von Hippel-Lindau (VHL) - Vascular Tumors\nâ”‚   â””â”€â”€ Sturge-Weber Syndrome - Port Wine & Seizures\nâ”‚\nâ”œâ”€â”€ 2. Neural Tube Defects (Spine) ğŸ¦´\nâ”‚   â”œâ”€â”€ Spina Bifida Occulta (Hidden)\nâ”‚   â”œâ”€â”€ Meningocele (Sac with fluid)\nâ”‚   â””â”€â”€ Myelomeningocele (Sac with nerves - Severe)\nâ”‚\nâ”œâ”€â”€ 3. Scalp Swellings (Newborn Head Lumps) ğŸ¤•\nâ”‚   â”œâ”€â”€ Caput Succedaneum (Edema)\nâ”‚   â”œâ”€â”€ Cephalohematoma (Blood, Sub-periosteal)\nâ”‚   â””â”€â”€ Subgaleal Hemorrhage (Dangerous!)\nâ”‚\nâ”œâ”€â”€ 4. Head Size Anomalies ğŸ“\nâ”‚   â”œâ”€â”€ Hydrocephalus (Water on brain)\nâ”‚   â”œâ”€â”€ Microcephaly (Small head)\nâ”‚   â””â”€â”€ Macrocephaly (Big head)\nâ”‚\nâ””â”€â”€ 5. Cerebral Palsy (Motor) â™¿\n    â”œâ”€â”€ Spastic Diplegia (Prematurity)\n    â””â”€â”€ Hemiplegia (Stroke/Vascular)`\n---\n### 1. Neurocutaneous Disorders (The Phakomatoses) ğŸ§¬\n**Core Concept:** í”¼ë¶€(Skin)ì™€ ë‡Œ(Nervous System)ëŠ” ë°œìƒí•™ì ìœ¼ë¡œ ëª¨ë‘ **Ectoderm(ì™¸ë°°ì—½)**ì—ì„œ ìœ ë˜í•œ ìŒë‘¥ì´ì…ë‹ˆë‹¤. í”¼ë¶€ì˜ \"Blueprints\"ê°€ ì—‰ë§ì´ë¼ë©´(messy), ì‹ ê²½ê³„ì˜ \"Blueprints\"ë„ ì—‰ë§ì¼ í™•ë¥ ì´ ë†’ìŠµë‹ˆë‹¤! ğŸš©\n### A. Neurofibromatosis Type 1 (NF1)\n- **Genetic:** Mutation in **NF1 gene** on **Chromosome 17**.\n    - *Mnemonic:* von Recklinghausen's disease (ì´ë¦„ì´ ê¸¸ì£ ? 17ê¸€ì ì •ë„ ë¨ â†’  Chr 17)\n- **Protein:** **Neurofibromin** (Tumor Suppressor, RAS pathwayì˜ break pedal ì—­í• ). ë¸Œë ˆì´í¬ê°€ ê³ ì¥ ë‚˜ì„œ ì„¸í¬ê°€ ê³„ì† ë¶„ì—´í•¨.\n- **Clinical Presentation (Doorway Clues):**\n    - **Skin:** **CafÃ©-au-lait spots** â˜• (6ê°œ ì´ìƒì´ì–´ì•¼ í•¨). \"Spilled latte look\".\n    - **Axillary/Inguinal Freckling:** ê²¨ë“œë‘ì´ë‚˜ ì‚¬íƒ€êµ¬ë‹ˆì˜ ì£¼ê·¼ê¹¨.\n    - **Eye:** **Lisch Nodules** (Irisì˜ ê°ˆìƒ‰ ë©ì–´ë¦¬ë“¤ - Visionì—ëŠ” ì˜í–¥ ì—†ìŒ, ì§„ë‹¨ì  ê°€ì¹˜ë§Œ ìˆìŒ).\n    - **Tumors:** **Neurofibromas** (í”¼ë¶€ ë°‘ì˜ ë§ë‘ë§ë‘í•œ ë©ì–´ë¦¬, 'Button-hole' sign), Optic Glioma.\n    - **Bone:** Skeletal dysplasia.\n### B. Neurofibromatosis Type 2 (NF2)\n- **Genetic:** Mutation in **NF2 gene** on **Chromosome 22**.\n    - *Mnemonic:* Type 2ë‹ˆê¹Œ 2ê°€ ë‘ ê°œ â†’  22ë²ˆ ì—¼ìƒ‰ì²´.\n- **Protein:** **Merlin** (ì„¸í¬ ê³¨ê²© ì•ˆì •í™” ë‹¨ë°±ì§ˆ). Schwann cellì´ ë¯¸ì¹œ ë“¯ì´ ìë¼ë‚¨.\n- **Clinical Presentation:**\n    - **Ears (â˜…Key):** **Bilateral Vestibular Schwannomas** (Acoustic Neuromas).\n        - ì¦ìƒ: Hearing loss, Tinnitus (ì´ëª…), Balance issues.\n    - **Eyes:** **Juvenile Cataracts** (ë°±ë‚´ì¥).\n    - *Note:* Skin findingì€ NF1ë³´ë‹¤ í›¨ì”¬ ì ìŒ.\n### C. Tuberous Sclerosis Complex (TSC)\n- **Genetic:** TSC1 or TSC2 mutation. **mTOR pathway** ì¡°ì ˆ ì‹¤íŒ¨ â†’  \"Multi-system Chaos\" (ë‡Œ, í”¼ë¶€, ì‹¬ì¥, ì‹ ì¥ ë‹¤ ì»¤ì§).\n- **Clinical Presentation:**\n    - **Skin (â˜…First Sign):** **Ash-leaf spots** (Hypopigmented macules).\n        - **Next Best Step:** **Wood's Lamp** (UV light) examination to see them clearly.\n    - **Face:** **Adenoma Sebaceum** (Facial Angiofibromas) - ì½”ì™€ ëº¨ ì£¼ë³€ì˜ ë¶‰ì€ ì—¬ë“œë¦„ ê°™ì€ ê²ƒë“¤ (Acneì™€ ë‹¬ë¦¬ ë”±ë”±í•˜ê³  í”¼ê°€ ì˜ ë‚¨).\n    - **Back:** **Shagreen Patch** (Orange peel/Leather texture).\n    - **Fingers:** **Ungual Fibromas** (ì†í†± ì£¼ë³€ì˜ ì„¬ìœ ì¢…).\n    - **Brain:** **Cortical Tubers**, **Subependymal Giant Cell Astrocytoma (SEGA)**.\n        - â†’  ì›ì¸ ë¶ˆëª…ì˜ **Seizures** (íŠ¹íˆ Infantile Spasms - West Syndrome) + Intellectual Disability / Autism.\n    - **Heart:** **Cardiac Rhabdomyoma** (ì‹ ìƒì•„ ì‹¬ì¥ ì¢…ì–‘ì˜ m/c cause).\n    - **Kidney:** **Renal Angiomyolipoma**.\n### D. Von Hippel-Lindau (VHL)\n- **Genetic:** VHL gene on **Chromosome 3**. (VHL ì„¸ ê¸€ì â†’  3ë²ˆ)\n- **Protein:** pVHL (HIF-1a ë¶„í•´). ì´ê²Œ ê³ ì¥ ë‚˜ë©´ ëª¸ì´ \"ì‚°ì†Œ ë¶€ì¡±í•´!\"ë¼ê³  ì°©ê°í•´ì„œ í˜ˆê´€ì„ ë§ˆêµ¬ ë§Œë“¦ (Angiogenesis).\n- **Clinical Presentation (Tumors everywhere):**\n    - **Hemangioblastomas:** Retina (Vision loss), Cerebellum (Balance issues).\n    - **Renal Cell Carcinoma (RCC):** ì‹ ì¥ì•” (Clear cell type).\n    - **Pheochromocytoma:** ë¶€ì‹  ì¢…ì–‘.\n### E. Sturge-Weber Syndrome","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-185","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","treatment","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"- **Genetic:** **Somatic Mosaicism** (GNAQ gene). **NOT Inherited!** (ìœ ì „ë˜ì§€ ì•ŠìŒ).\n- **Pathology:** í˜ˆê´€ ê¸°í˜•(Vascular malformation). \"GNAQ mutation\"\n- **Clinical Presentation:**\n    - **Face:** **Port-Wine Stain** (Nevus Flammeus) in **V1/V2 distribution** (Trigeminal nerve).\n    - **Brain:** ê°™ì€ ìª½(Ipsilateral) ë‡Œë§‰ì˜ **Leptomeningeal Angioma**.\n        - abnormal vein â†’ congestion â†’ í˜ˆë¥˜ê³µê¸‰ â†“\n        - ë‡Œê°€ ì„íšŒí™”ë¨ (Tram-track Calcifications).\n        - â†’  ë‡Œê°€ ì„íšŒí™”ë¨ (**Tram-track Calcifications**).\n        - â†’  ë°˜ëŒ€ìª½(Contralateral) **Seizures** & **Hemiparesis** (í¸ë§ˆë¹„).\n    - **Eye:** **Glaucoma** (ë…¹ë‚´ì¥) - ì•ˆì•• ìƒìŠ¹ ì£¼ì˜! ğŸ‘ï¸Â (í˜ˆë¥˜ ë¬¸ì œ â†’ ì••ë ¥ ìƒìŠ¹ìœ¼ë¡œ ì¸í•´ ë…¹ë‚´ì¥ìƒê¹€)\n---\n### 2. Neural Tube Defects (Spina Bifida) ğŸ¦´\n**Mechanism:** Neural tubeê°€ ì œëŒ€ë¡œ ë‹«íˆì§€ ì•Šì€ \"Zipper\" ê³ ì¥.\n**Prevention:** **Folic Acid (ì—½ì‚°)** ì„­ì·¨ê°€ í•„ìˆ˜! (Maternal deficiencyê°€ ì£¼ì›ì¸)\n### Types (Severity ìˆœì„œ)\n1. **Spina Bifida Occulta (Hidden):**\n- ë¼ˆ(Vertebrae)ë§Œ ì•ˆ ë‹«í˜. ì²™ìˆ˜ëŠ” ì •ìƒ.\n- **Sign:** í—ˆë¦¬ ì•„ë˜ìª½(Gluteal crease ìœ„)ì— **Tuft of Hair** (í„¸ ë­‰ì¹˜), Dimple, or Lipoma.\n- **Complication:** **Tethered Cord Syndrome** (ì²™ìˆ˜ê°€ ë¼ˆì— ë“¤ëŸ¬ë¶™ì–´ í‚¤ê°€ í´ ë•Œ ì²™ìˆ˜ê°€ ë‹¹ê²¨ì§ â†’  Bladder/Bowel dysfunction, Leg weakness).\n![image.png](LM_Neuro%203/image.png)\n![image.png](LM_Neuro%203/image%201.png)\n1. **Meningocele:**\n    - ì£¼ë¨¸ë‹ˆ(Sac)ê°€ íŠ€ì–´ë‚˜ì˜´. ì•ˆì—ëŠ” **Fluid(CSF)**ì™€ Meningesë§Œ ìˆìŒ. ì‹ ê²½(Nerve)ì€ ì—†ìŒ.\n2. **Myelomeningocele (ê°€ì¥ ì‹¬ê°):**\n    - ì£¼ë¨¸ë‹ˆ ì•ˆì— **Spinal Cord(Nerve)**ê°€ ë“¤ì–´ìˆìŒ.\n    - ì¦ìƒ: í•´ë‹¹ ë ˆë²¨ ì´í•˜ì˜ ë§ˆë¹„(Paralysis), ê°ê° ì†Œì‹¤. **Chiari II Malformation** (ì†Œë‡Œê°€ ì²™ìˆ˜ë¡œ ë¹ ì§) ë° **Hydrocephalus** ë™ë°˜ ê°€ëŠ¥ì„± ë†’ìŒ.\n### Management with Bladder Problems\n- urinary catheter ìì£¼ ë„£ì–´ì¤˜ì„œ ì˜¤ì¤Œ ëºŒ to prevent kidney problems.\n---\n### 3. Scalp Swellings (Newborn Head Lumps) ğŸ¤•\nì‹ ìƒì•„ê°€ íƒœì–´ë‚  ë•Œ ë¨¸ë¦¬ì— í˜¹ì´ ë‚¬ë‹¤? ì¸µ(Layer)ì„ ì•„ëŠ” ê²ƒì´ ì¤‘ìš”í•©ë‹ˆë‹¤!\n![image.png](LM_Neuro%203/image%202.png)\n| **íŠ¹ì§•** | **Caput Succedaneum = ë©** | **Cephalohematoma = â€˜í”¼â€™ë©** | **Subgaleal Hemorrhage\n=ë„“ì€ ê³µê°„ì— í”¼ì°¸** |\n| --- | --- | --- | --- |\n| **ìœ„ì¹˜** | Skin (Subcutaneous) | Under Periosteum (ê³¨ë§‰ ì•„ë˜) | Subgaleal space (Emissary veins) |\n| **ë‚´ìš©ë¬¼** | Serosanguinous fluid (Edema) | **Blood** | **Blood** (Massive) |\n| **Suture Line** | **Crosses Sutures** (ë§‰ ê±´ë„ˆê°) | **Does NOT Cross** (ë¼ˆì— ê°‡í˜) | **Crosses Sutures** (ê·€ì—ì„œ ê·€ê¹Œì§€) |\n| **ëŠë‚Œ** | Soft, Boggy (ë¬¼ë ë¬¼ë ) | Firm boundaries (ë‹¨ë‹¨í•¨) | Boggy, diffuse waves (ì¶œë ê±°ë¦¼) |\n| **ìœ„í—˜ë„** | Benign (ë©°ì¹  ë‚´ ì‚¬ë¼ì§) | **Hyperbilirubinemia** (í™©ë‹¬) | **Life-Threatening** (Shock!) ğŸš¨ |\n| **Note** | \"Caput\" = Cap(ëª¨ì)ì„ ì“°ë©´ ë´‰í•©ì„ ì„ ë„˜ì–´ê°€ë“¯. | ë¼ˆ ëª¨ì–‘ ê·¸ëŒ€ë¡œ í˜¹ì´ ë‚¨. | í”¼ê°€ ì—„ì²­ë‚˜ê²Œ ê³ ì—¬ì„œ ì‡¼í¬ì‚¬ ê°€ëŠ¥. |\n---\n### 4. Head Size Anomalies ğŸ“","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-205","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"### A. Hydrocephalus (ìˆ˜ë‘ì¦)\n- **Concept:** \"Plumbing issue\". CSFê°€ ë¹ ì ¸ë‚˜ê°€ì§€ ëª»í•¨ (Obstruction) or ë„ˆë¬´ ë§ì´ ìƒì„±ë¨.\n- **Symptoms:**\n    - Rapidly increasing head circumference.\n    - **Bulging Fontanelle** (ëŒ€ì²œë¬¸ íŒ½ì°½).\n    - **Sun-set Eyes:** ëˆˆì´ ì•„ë˜ë¡œ ê¹”ë¦¼ (Midbrain pressure â†’  Upward gaze palsy).\n- **Cause:** Intraventricular Hemorrhage (Preemie), Tumors, Chiari Malformation.\n### B. Microcephaly (ì†Œë‘ì¦)\n- **Definition:** Head circumference **< 3rd percentile**.\n- **Algorithm (First Step):**\n    - **Measure Mom & Dad's heads!** ğŸ‘¨â€ğŸ‘©â€ğŸ‘§\n    - ë¶€ëª¨ ë¨¸ë¦¬ê°€ ì‘ë‹¤? â†’  **Benign Familial Microcephaly** (No workup needed).\n    - ë¶€ëª¨ëŠ” ì •ìƒì´ë‹¤? â†’  Pathologic (Zika virus, Genetic, TORCH infection ë“±).\n### C. Macrocephaly (ëŒ€ë‘ì¦)\n- **Definition:** Head circumference **> 97th percentile**.\n- **Causes:** Hydrocephalus, Familial, Canavan disease, Alexander disease etc.\n---\n### 5. Cerebral Palsy (CP) â™¿\n**Definition:** **Permanent, NON-progressive** motor disorder. (ë‡Œ ì†ìƒ;ì£¼ë¡œ í˜ˆë¥˜ ì†ìƒ ë¬¸ì œ;ì€ í•œ ë²ˆ ì¼ì–´ë‚¬ê³ , ë” ë‚˜ë¹ ì§€ì§€ëŠ” ì•ŠìŒ. ì¦ìƒì€ ì•„ì´ê°€ í¬ë©´ì„œ ë‹¬ë¼ ë³´ì¼ ìˆ˜ ìˆìŒ).\n### A. Spastic Diplegia (ì–‘í•˜ì§€ ë§ˆë¹„)\n- **Risk Factor:** **Prematurity** (ë¯¸ìˆ™ì•„).\n- **Pathophysiology:** **Periventricular Leukomalacia (PVL)**.\n    - ë‡Œì‹¤ ì£¼ë³€(Periventricular)ì˜ White matterê°€ ê´´ì‚¬í•¨. ì´ê³³ì— **ë‹¤ë¦¬(Legs)**ë¡œ ê°€ëŠ” ìš´ë™ ì‹ ê²½ì´ ì§€ë‚˜ê°.\n    - ë¯¸ìˆ™ì•„ëŠ” í˜ˆë¥˜ ë°œì „ì´ ì˜ë˜ì§€ ì•Šì•„ì„œ ì €ë¶€ë¶„ì´ ischemic changeì— ì·¨ì•½í•¨.\n- **Presentation:**\n    - **Legs > Arms** (ë‹¤ë¦¬ê°€ ë” ë»£ë»£í•˜ê³  ì•½í•¨).\n    - **\"Commando Crawl\"**: íŒ”ë¡œë§Œ ê¸°ì–´ ë‹¤ë‹ˆê³  ë‹¤ë¦¬ëŠ” ì§ˆì§ˆ ë”. ğŸª–\n    - **Scissoring gait**: ê±¸ì„ ë•Œ ë‹¤ë¦¬ê°€ ê°€ìœ„ì²˜ëŸ¼ êµì°¨ë¨.\n### B. Spastic Hemiplegia (í¸ë§ˆë¹„)\n- **Risk Factor:** Perinatal Stroke, Vascular insult.\n- **Presentation:** ëª¸ì˜ í•œìª½(Left or Right)ë§Œ ë§ˆë¹„.\n- **â˜… Red Flag:** **Early Hand Preference (< 18 months)**.\n    - 18ê°œì›” ì´ì „ì— ì˜¤ë¥¸ì†ì¡ì´/ì™¼ì†ì¡ì´ê°€ ëšœë ·í•˜ë‹¤ë©´? ë°˜ëŒ€ìª½ ì†ì„ *ëª» ì¨ì„œ* ê·¸ëŸ´ ìˆ˜ ìˆìŒ. ì´ëŠ” Hemiparesisì˜ ê°•ë ¥í•œ ì‹ í˜¸!\n### Management\n- **Goal:** Functionality & Comfort.\n- **Tx:** **Botox** injections (ê·¼ìœ¡ ì´ì™„), **Baclofen** (GABA agonist - spasticity ê°ì†Œ), Physical Therapy.\n---","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-225","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","tree"]}
{"chunk_type":"recap_summary","text":"### âš¡ Rapid Fire Recap (Summary Table)\n| **Condition** | **Key Clinical Feature / Buzzword** | **Pathophysiology / Gene** |\n| --- | --- | --- |\n| **NF1** | CafÃ©-au-lait, Lisch nodules, Neurofibromas | Chr 17, Neurofibromin |\n| **NF2** | **Bilateral Acoustic Neuromas** (Hearing loss) | Chr 22, Merlin |\n| **Tuberous Sclerosis** | **Ash-leaf spots**, Cardiac Rhabdomyoma, Seizures | TSC1/2, mTOR pathway |\n| **Sturge-Weber** | **Port-Wine Stain**, Seizures (Contralateral) | Somatic GNAQ (Not inherited) |\n| **VHL** | Hemangioblastomas (Retina/Cerebellum), RCC | Chr 3, VHL gene |\n| **Cephalohematoma** | Does **NOT** cross sutures | Subperiosteal blood (Risk: Jaundice) |\n| **Subgaleal Hemorrhage** | **Crosses** sutures, Fluctuant | Emissary veins (Risk: Shock/Death) |\n| **Spastic Diplegia** | **Commando Crawl**, Legs > Arms | Prematurity â†’  PVL |\n---\n- ì˜¤ë””ì˜¤ ê°•ì˜ëŠ” \"General Rule\"ì„ ë‹¤ë£¹ë‹ˆë‹¤. ì˜ˆì™¸ì ì¸ ì¼€ì´ìŠ¤(Mosaicism in NF, etc.)ëŠ” í•­ìƒ ì¡´ì¬í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n- CPì˜ ì§„ë‹¨ì€ ì„ìƒì (Clinical)ì´ì§€ë§Œ, í™•ì§„ì„ ìœ„í•´ MRIê°€ í•„ìš”í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n- Scalp swelling ì¤‘ Subgaleal hemorrhageëŠ” ì‘ê¸‰ ìƒí™©ì„ì„ ê¼­ ê¸°ì–µí•˜ì„¸ìš”!\n**Overview: Pediatric Acute Neurology Deep Dive**\nì•ˆë…•í•˜ì„¸ìš”! ì˜¤ëŠ˜ì€ ì†Œì•„ ì‘ê¸‰ ì‹ ê²½í•™(Pediatric Acute Neurology)ì— ëŒ€í•´ ì•„ì£¼ ê¹Šì´ ìˆê²Œ íŒŒê³ ë“¤ì–´ ë³´ê² ìŠµë‹ˆë‹¤. ğŸ§ âš¡ï¸ ë¯¸êµ­ ì˜ì‚¬ êµ­ê°€ê³ ì‹œ(USMLE)ë‚˜ ì„ìƒ í˜„ì¥ì—ì„œ ì •ë§ ì¤‘ìš”í•˜ê²Œ ë‹¤ë£¨ëŠ” **Stroke, IVH, ê·¸ë¦¬ê³  ë‹¤ì–‘í•œ Pediatric Epilepsy Syndromes**ë¥¼ ë‚˜ì´ëŒ€ë³„, ìƒí™©ë³„ë¡œ ì™„ë²½í•˜ê²Œ ì •ë¦¬í•´ ë“œë¦´ê²Œìš”.\nì´ ê°•ì˜ëŠ” \"High-Yield Tutoring Session\" ì»¨ì…‰ìœ¼ë¡œ ì§„í–‰ë©ë‹ˆë‹¤. ë†“ì¹˜ëŠ” ë‚´ìš© ì—†ì´ ê½‰ê½‰ ì±„ì› ìœ¼ë‹ˆ ì§‘ì¤‘í•´ ì£¼ì„¸ìš”! ğŸ”¥\n### **Top-down Classification & Structure (ASCII Text Tree)**","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-241","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","recap","pathophysiology","tree"]}
{"chunk_type":"transcript_chunk","text":"ì´ êµ¬ì¡°ë¥¼ ë¨¸ë¦¿ì†ì— ë¨¼ì € ë„£ê³  ì„¸ë¶€ ë‚´ìš©ì„ ì±„ì›Œë„£ìœ¼ì„¸ìš”. ğŸŒ³\nPlaintext\n`Pediatric Acute Neurology (ì†Œì•„ ê¸‰ì„± ì‹ ê²½í•™)\nâ”‚\nâ”œâ”€â”€ 1. Acute Hemiplegia (ê¸‰ì„± í¸ë§ˆë¹„: The Scary Door)\nâ”‚   â”œâ”€â”€ Ischemic Stroke (í—ˆí˜ˆì„± ë‡Œì¡¸ì¤‘)\nâ”‚   â”‚   â””â”€â”€ ì›ì¸: Cardiac defects, Sickle cell, Prothrombotic d/o\nâ”‚   â”œâ”€â”€ Hemorrhagic Stroke (ì¶œí˜ˆì„± ë‡Œì¡¸ì¤‘)\nâ”‚   â”‚   â””â”€â”€ ì›ì¸: Trauma, Bleeding d/o (Hemophilia), AVM\nâ”‚   â””â”€â”€ Todd's Paralysis (í† ë“œ ë§ˆë¹„)\nâ”‚       â””â”€â”€ â˜… Diagnosis of Exclusion (ë°°ì œ ì§„ë‹¨)! ì ˆëŒ€ ë¨¼ì € ê°€ì •í•˜ì§€ ë§ ê²ƒ.\nâ”‚\nâ”œâ”€â”€ 2. Intraventricular Hemorrhage (IVH: The Quiet Door)\nâ”‚   â”œâ”€â”€ ëŒ€ìƒ: Premature infants (<32 weeks)\nâ”‚   â”œâ”€â”€ í•´ë¶€í•™ì  ì›ì¸: Germinal Matrix fragility (ì•½í•œ í˜ˆê´€)\nâ”‚   â”œâ”€â”€ Screening: Head Ultrasound (Routine for preemies)\nâ”‚   â””â”€â”€ í•©ë³‘ì¦: Hydrocephalus (Communicating)\nâ”‚\nâ”œâ”€â”€ 3. Pediatric Epilepsy Syndromes (Age-Dependent Patterns)\nâ”‚   â”œâ”€â”€ Infantile Spasms (West Syndrome, <1 yr)\nâ”‚   â”‚   â”œâ”€â”€ SX: Jackknife spasms\nâ”‚   â”‚   â”œâ”€â”€ EEG: Hypsarrhythmia\nâ”‚   â”‚   â””â”€â”€ TX: ACTH (Adrenocorticotropic hormone)\nâ”‚   â”œâ”€â”€ Lennox-Gastaut Syndrome (Toddler/Child, 3-5 yrs)\nâ”‚   â”‚   â”œâ”€â”€ SX: Regression, Intellectual disability\nâ”‚   â”‚   â””â”€â”€ EEG: Slow spike-and-wave\nâ”‚   â””â”€â”€ Juvenile Myoclonic Epilepsy (JME, Teenager)\nâ”‚       â”œâ”€â”€ SX: Morning myoclonus (ì–‘ì¹˜ì§ˆí•˜ë‹¤ ì¹«ì†” ë˜ì§)\nâ”‚       â”œâ”€â”€ Trigger: Alcohol, Sleep deprivation\nâ”‚       â””â”€â”€ TX: Valproic Acid\nâ”‚\nâ””â”€â”€ 4. Febrile Seizures (ì—´ì„± ê²½ë ¨)\n    â”œâ”€â”€ Simple Febrile Seizure (ë‹¨ìˆœ)\n    â”‚   â””â”€â”€ <15min, Generalized, 1x/24hr â†’ Reassurance\n    â””â”€â”€ Complex Febrile Seizure (ë³µí•©)\n        â””â”€â”€ >15min, Focal, >1x/24hr â†’ Workup needed`\n---\n## **Part 1: Acute Hemiplegia & Stroke in Children (Door #1)** ğŸšªğŸƒâ€â™‚ï¸ğŸ’¨\n### **1. The Clinical Scenario (Vignette Anchor)**\n- **ìƒí™©:** 3ì„¸ ì•„ì´ê°€ ë¸”ë¡ ë†€ì´ë¥¼ í•˜ë‹¤ê°€ ê°‘ìê¸° ì˜¤ë¥¸ìª½ íŒ”ë‹¤ë¦¬ì— í˜ì´ ë¹ ì§€ë©´ì„œ ì¶• ëŠ˜ì–´ì§ (Dead weight/Limp).\n- **ë¶€ëª¨ ë°˜ì‘:** íŒ¨ë‹‰ ìƒíƒœë¡œ ì‘ê¸‰ì‹¤ë¡œ ë›°ì–´ ë“¤ì–´ì˜´.\n- **ì˜ì‚¬ì˜ ë”œë ˆë§ˆ:** \"ì„¤ë§ˆ ì• í•œí…Œ ë‡Œì¡¸ì¤‘(Stroke)ì´?\"ë¼ê³  ìƒê°í•˜ë©° ì£¼ì €í•˜ê²Œ ë¨.\n### **2. Differential Diagnosis Table: Why do kids get strokes?**\nì–´ë¥¸ë“¤ì˜ ë‡Œì¡¸ì¤‘(ì£½ìƒê²½í™”ì¦, í¡ì—° ë“±)ê³¼ëŠ” ì›ì¸ì´ ì™„ì „íˆ ë‹¤ë¦…ë‹ˆë‹¤! ğŸ™…â€â™‚ï¸\n| **Type** | **Key Etiologies (ì›ì¸)** | **ë¹„ê³ ** |\n| --- | --- | --- |\n| **Ischemic Stroke** (í—ˆí˜ˆì„±) | â€¢ **Cardiac Disease:** ì„ ì²œì„± ì‹¬ì¥ ê¸°í˜• (Patent Foramen Ovale ë“±)\nâ€¢ **Hematologic:** **Sickle Cell Disease** (SCD, ë§¤ìš° ì¤‘ìš”!), Prothrombotic disorders | êµ¬ì¡°ì (Structural) ë¬¸ì œë‚˜ í˜ˆì•¡í•™ì  ë¬¸ì œê°€ ë©”ì¸! |\n| **Hemorrhagic Stroke** (ì¶œí˜ˆì„±) | â€¢ **Trauma:** ì†Œì•„ì—ì„œ ê°€ì¥ í° ì›ì¸ ì¤‘ í•˜ë‚˜\nâ€¢ **Bleeding Disorders:** Hemophilia (í˜ˆìš°ë³‘), Vitamin K deficiency\nâ€¢ **Vascular:** AVM (ë™ì •ë§¥ê¸°í˜•) | ë„˜ì–´ì ¸ì„œ ë¨¸ë¦¬ë¥¼ ë¶€ë”ªíˆê±°ë‚˜, í˜ˆì•¡ ì‘ê³  ì¥ì• ê°€ ìˆëŠ” ê²½ìš°. |\n| Toddâ€™s Paralysis (ë°œì‘ í›„ í•œìª½ ë§ˆë¹„) | ì•„ë˜ ì°¸ê³  |  |\n| Hemiplegic Migraine |   â€¢ ì²­ì†Œë…„ê¸°ì—ì„œ í¸ë‘í†µê³¼ ê´€ë ¨ëœ í˜ë¹ ì§\n  â€¢ Familiy history. ì—„ë§ˆì—ì„œë„ ê°™ì€ ë¬¸ì œ  |  |\n### **3. The Trap: Todd's Paralysis (í† ë“œ ë§ˆë¹„) âš ï¸**\n- **ì •ì˜:** ë°œì‘(Seizure) í›„ ì¼ì‹œì ìœ¼ë¡œ í•œìª½ ë§ˆë¹„(Hemiparesis)ê°€ ì˜¤ëŠ” í˜„ìƒ.\n- **íŠ¹ì§•:**\n    - Self-resolving (ì €ì ˆë¡œ ì¢‹ì•„ì§).\n    - ë³´í†µ ëª‡ ì‹œê°„ ë‚´ì— íšŒë³µë¨.\n    - ë°œì‘ í›„ í˜¼ë€ ìƒíƒœ(Post-ictal confusion/groggy) ë™ë°˜.\n- **â˜… WARNING (Board Trap):** \"Todd's Paralysis\"ëŠ” **ë°°ì œ ì§„ë‹¨(Diagnosis of Exclusion)**ì…ë‹ˆë‹¤!\n    - ì ˆëŒ€ë¡œ \"ì•„, ë°©ê¸ˆ ë°œì‘í–ˆìœ¼ë‹ˆê¹Œ ë§ˆë¹„ëŠ” ê·¸ëƒ¥ Todd's Paralysisê² ì§€? ê¸°ë‹¤ë ¤ë³´ì.\"ë¼ê³  ë‹¨ì • ì§€ìœ¼ë©´ ì•ˆ ë©ë‹ˆë‹¤. âŒ\n    - **Gold Standard:** ë°˜ë“œì‹œ Strokeì„ ë¨¼ì € ë°°ì œí•´ì•¼ í•¨.\n### **4. Workup & Management** ğŸ¥\n- **Next Best Step (Diagnosis):** **MRI of the Brain + MRA (Magnetic Resonance Angiography)** â˜…\n    - ì¼ë°˜ MRIë¡œëŠ” ë¶€ì¡±í•©ë‹ˆë‹¤. ì†Œì•„ ë‡Œì¡¸ì¤‘ì€ í˜ˆê´€ ê¸°í˜•(Vascular anomaly)ì´ë‚˜ ë§‰í˜(Occlusion)ì„ í™•ì¸í•´ì•¼ í•˜ë¯€ë¡œ **MRA(í˜ˆê´€ ì¡°ì˜)**ê°€ í•„ìˆ˜ì…ë‹ˆë‹¤. Urgentí•˜ê²Œ ì‹œí–‰í•´ì•¼ í•©ë‹ˆë‹¤.\n---\n## **Part 2: Intraventricular Hemorrhage (IVH) (Door #2)** ğŸšªğŸ¤«ğŸ‘¶\n###","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-251","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"### **2. Pathophysiology: The Plumping Problem** ğŸ©¸\n- **ëŒ€ìƒ:** **Premature Infants (ë¯¸ìˆ™ì•„)**, íŠ¹íˆ **32ì£¼ ë¯¸ë§Œ** ì¶œìƒì•„.\n- **í•µì‹¬ êµ¬ì¡°ë¬¼:** **Germinal Matrix (ë°°ì•„ê¸°ì§ˆ)**\n    - ë‡Œì‹¤(Ventricle) ê·¼ì²˜ì— ìœ„ì¹˜í•˜ë©°, ìƒˆë¡œìš´ ë‡Œì„¸í¬ê°€ ë§Œë“¤ì–´ì§€ëŠ” ê³³.\n    - ì´ê³³ì˜ í˜ˆê´€ì€ ë§ˆì¹˜ **\"ì –ì€ íœ´ì§€(Wet tissue paper)\"**ì²˜ëŸ¼ ë§¤ìš° ì•½í•©ë‹ˆë‹¤. (Structural supportê°€ ì—†ìŒ).\n- **ê¸°ì „:** ë¯¸ìˆ™ì•„ì˜ í˜ˆì•• ë³€í™”, í˜¸í¡ ê³¤ë€(Respiratory distress) ë“±ìœ¼ë¡œ ì¸í•œ ìŠ¤íŠ¸ë ˆìŠ¤ â†’ ì•½í•œ í˜ˆê´€ì´ í‘ í„°ì§ â†’ ë‡Œì‹¤ ë‚´ ì¶œí˜ˆ(IVH).\n### **3. Diagnosis & Screening** ğŸ–¥ï¸\n- **Clinical Signs:**\n    - ìµœëŒ€ 50%ëŠ” **Clinically Silent (ë¬´ì¦ìƒ)**. ğŸ˜±\n    - ì‹¬í•œ ê²½ìš°: ë¶ˆë£©í•œ ëŒ€ì²œë¬¸(Bulging fontanelle), ë¹ˆí˜ˆ(Anemia), ë¬´í˜¸í¡(Apnea).\n- **Imaging (Gold Standard):** **Cranial Ultrasound (ë‡Œ ì´ˆìŒíŒŒ)** â˜…\n    - CTë¥¼ ì°ì§€ ì•ŠìŠµë‹ˆë‹¤ (ë°©ì‚¬ì„  í”¼í­ ë°©ì§€).\n    - **Protocol:** ëª¨ë“  32ì£¼ ë¯¸ë§Œ ë¯¸ìˆ™ì•„ëŠ” ì¦ìƒì´ ì—†ë”ë¼ë„ **Routine Screening Ultrasound**ë¥¼ ì‹œí–‰í•´ì•¼ í•©ë‹ˆë‹¤. (Must memorize!)\n    - ì´ˆìŒíŒŒì—ì„œ ë‡Œì‹¤ì€ ê·¸ëƒ¥ ê²€ì •ìƒ‰ì´ì—¬ì•¼í•˜ëŠ”ë° í•˜ì–€ìƒ‰ì¸ í”¼ê°€ ë³´ì¸ë‹¤ â˜…\n### **4. Complications**\n- **Post-Hemorrhagic Hydrocephalus:** í”¼ ë–¡(Blood clot)ì´ ë‡Œì²™ìˆ˜ì•¡(CSF) ë°°ì¶œêµ¬(Drain)ë¥¼ ë§‰ìŒ â†’ ë¨¸ë¦¬ê°€ ì»¤ì§€ê³  ë‡Œì•• ìƒìŠ¹.â†’ bulging fontanelle â†’ ì´ˆìŒíŒŒì°ìœ¼ì„¸ìš”.\n- **Management:** ë¨¸ë¦¬ ë‘˜ë ˆ(Head circumference)ë¥¼ ì£¼ê¸°ì ìœ¼ë¡œ ì¸¡ì •. í•„ìš”ì‹œ Shunt ìˆ˜ìˆ .\n---\n## **Part 3: Pediatric Epilepsy Syndromes (The Big Three)** ğŸ“‰ğŸ‘¶ğŸ‘¦ğŸ§‘\në‚˜ì´(Age)ì™€ íŒ¨í„´(Pattern)ì„ ë§¤ì¹­í•˜ëŠ” ê²ƒì´ ì‹œí—˜ì˜ í•µì‹¬ì…ë‹ˆë‹¤!\n### **1. Infantile Spasms (West Syndrome) - Infants (<1 yr) ğŸ‘¶**\n- **Key Feature:** **Jackknife Spasms** (ì­ë‚˜ì´í”„ì²˜ëŸ¼ ëª¸ì„ ì ‘ìŒ). (ë¶€ëª¨ë“¤ì´ ê·¸ëƒ¥ ë¬´ì‹œí•˜ê¸° ì‰¬ì›€. colicì´ë‚˜ ê·¸ëƒ¥ ê·€ì—¬ì›Œë³´ì´ëŠ” í–‰ë™..ì¸ì¤„..)\n- **EEG Finding:** **Hypsarrhythmia (ê³ ì£¼íŒŒë¶€ì •ë‡ŒíŒŒ)** â˜… - \"Chaotic, High amplitude, Disorganized scribbles.\"\n- **Treatment (Gold Standard):** **ACTH (Adrenocorticotropic Hormone)** â˜…\n    - ì¼ë°˜ì ì¸ í•­ê²½ë ¨ì œê°€ ì•„ë‹™ë‹ˆë‹¤! ìŠ¤í…Œë¡œì´ë“œ í˜¸ë¥´ëª¬ ìš”ë²•ì´ 1ì°¨ ì¹˜ë£Œì œì…ë‹ˆë‹¤.\n- **Prognosis:** ì¹˜ë£Œê°€ ëŠ¦ì–´ì§€ë©´ ì˜êµ¬ì ì¸ ë°œë‹¬ ì§€ì—°(Intellectual Disability) ì´ˆë˜. ì‘ê¸‰ ìƒí™©ì…ë‹ˆë‹¤!\n### **2. Lennox-Gastaut Syndrome - Toddlers/Children (3-5 yrs) ğŸ‘¦**\n- **Context:** ë³´í†µ ì´ì „ì— West Syndromeì„ ì•“ì•˜ë˜ ì•„ì´ê°€ ì§„í–‰ë˜ê±°ë‚˜, ë°œë‹¬ ì§€ì—°ì´ ìˆëŠ” ì•„ì´ì—ê²Œì„œ ë°œìƒ.\n- **Symptoms:**\n    - ì—¬ëŸ¬ ì¢…ë¥˜ì˜ ë°œì‘(Multiple seizure types: Atonic, Tonic, Absence etc.)\n    - **Regression (í‡´í–‰):** ì˜ í•˜ë˜ ë§ì„ ëª» í•˜ê±°ë‚˜ ë°œë‹¬ì´ ë©ˆì¶¤.\n    - Intellectual Disability (ì§€ì  ì¥ì• ) ë™ë°˜.\n- **EEG Finding:** **Slow Spike-and-Wave Pattern (< 2.5 Hz)** â˜…\n- **Takeaway:** ì˜ˆí›„ê°€ ì¢‹ì§€ ì•Šê³  ì¹˜ë£Œê°€ ì–´ë µìŠµë‹ˆë‹¤ (Refractory).\n### **3. Juvenile Myoclonic Epilepsy (JME) - Teenagers ğŸ§‘ğŸ¤**\n- **Vignette:** 10ëŒ€ ì²­ì†Œë…„. í•™êµ ê°€ê¸° ì „ ì•„ì¹¨, ì–‘ì¹˜ì§ˆí•˜ë‹¤ê°€ ì¹«ì†”ì„ ë–¨ì–´ëœ¨ë¦¼(Myoclonic jerk). í˜¹ì€ ì‹œë¦¬ì–¼ ê·¸ë¦‡ì„ ì—ìŒ. \"ë‹¨ìˆœíˆ ë¤ë²™ëŒ€ê±°ë‚˜ í”¼ê³¤í•´ì„œ\"ë¼ê³  ì°©ê°í•˜ê¸° ì‰¬ì›€.\n- **Pattern:** **Morning Myoclonus** (ì•„ì¹¨ì— ë°œìƒí•˜ëŠ” ê·¼ìœ¡ íŠ).\n- **Triggers:**\n    - **Sleep Deprivation (ìˆ˜ë©´ ë¶€ì¡±)**: ì‹œí—˜ ê¸°ê°„ ë°¤ìƒ˜ ê³µë¶€. ğŸ“š\n    - **Alcohol (ìˆ )**: ëŒ€í•™ ì‹ ì…ìƒ í™˜ì˜íšŒ ë‹¤ìŒ ë‚  ì•„ì¹¨ ë°œì‘. ğŸº\n- **EEG Finding:** **4-6 Hz Polyspike and Wave**.\n- **Treatment:** **Valproic Acid (ë°œí”„ë¡œì‚°)** â˜… (Lifelong medicationì¸ ê²½ìš°ê°€ ë§ìŒ).\n---\n## **Part 4: Febrile Seizures (ì—´ì„± ê²½ë ¨)** ğŸŒ¡ï¸ğŸ”¥","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-271","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"ë¶€ëª¨ë“¤ì´ ê°€ì¥ ë¬´ì„œì›Œí•˜ì§€ë§Œ, ì˜ì‚¬ëŠ” ê°€ì¥ ì¹¨ì°©í•´ì•¼ í•˜ëŠ” ìƒí™©ì…ë‹ˆë‹¤.\n### **1. Definitions & Classification (Must Memorize Table)**\n| **Feature** | **Simple Febrile Seizure (ë‹¨ìˆœ) âœ…** | **Complex Febrile Seizure (ë³µí•©) âš ï¸** |\n| --- | --- | --- |\n| **Duration (ì§€ì† ì‹œê°„)** | < 15 minutes (ì§§ìŒ) | > 15 minutes (ê¹€) |\n| **Type (í˜•íƒœ)** | Generalized (ì „ì‹  ë°œì‘, ì˜¨ëª¸ì„ ë–ª) | Focal (ë¶€ë¶„ ë°œì‘, í•œìª½ íŒ”ë§Œ ë–ª) |\n| **Frequency (ë¹ˆë„)** | 24ì‹œê°„ ë‚´ 1íšŒ | 24ì‹œê°„ ë‚´ 2íšŒ ì´ìƒ (ë°˜ë³µ) |\n| **Recovery** | ê¸ˆë°© íšŒë³µë¨ (Rapid return to baseline) | íšŒë³µì´ ëŠë¦¬ê±°ë‚˜ Todd's paralysis ë™ë°˜ ê°€ëŠ¥ |\n### **2. Management: The Rules** ğŸ“œ\n- **Simple Febrile Seizure:**\n    - **Action:** **Reassurance (ì•ˆì‹¬ì‹œí‚¤ê¸°)** & Discharge (ê·€ê°€).\n    - NO Imaging (CT/MRI X), NO EEG X.\n    - í•´ì—´ì œ(Antipyretics like Acetaminophen)ëŠ” ì—´ì„ ë‚´ë¦¬ì§€ë§Œ ë°œì‘ ì¬ë°œì„ ë§‰ì§€ëŠ” ëª»í•¨. (ë¶€ëª¨ êµìœ¡ í¬ì¸íŠ¸)\n- **Complex Febrile Seizure:**\n    - **Action:** Workup í•„ìš”. ì…ì› ê³ ë ¤, ë‡ŒíŒŒ(EEG)ë‚˜ MRI ê³ ë ¤ ê°€ëŠ¥. ë­”ê°€ ë‹¤ë¥¸ ì›ì¸ì´ ìˆëŠ”ì§€ ì°¾ì•„ë´ì•¼ í•¨.\n    - LP (r/o meningitis, r/o encephalitis), EEG, Imaging\n    - BZ to abort the seizure\n### **3. The Meningitis Fear (ë‡Œìˆ˜ë§‰ì—¼ ê°ë³„)** ğŸ¦ \n- ì—´ + ê²½ë ¨ = Meningitis?? í•­ìƒ ê³ ë¯¼ë˜ëŠ” ë¶€ë¶„.\n- ì•„ë˜ì— í•´ë‹¹ë˜ë©´ LPë¥¼ í•˜ê³  antibioticsê³ ë ¤í•œë‹¤.\n- **Lumbar Puncture (LP, ë‡Œì²™ìˆ˜ì•¡ ê²€ì‚¬) Indications:**\n    - PE sign: Meningeal Signs (ëª© ë»£ë»£í•¨, Kernig/Brudzinski sign), bulging fontanelle\n    - **Altered Mental Status (ì˜ì‹ ë³€í™”):** ë°œì‘ í›„ ê¸ˆë°© ê¹¨ì§€ ì•Šê³  ê³„ì† ì²˜ì ¸ ìˆì„ ë•Œ (>10-15ë¶„ ì´ìƒ). post ictal confusionì´ ê¸¸ë‹¤.\n    - **Unvaccinated (ë°±ì‹  ë¯¸ì ‘ì¢…):** Hib, Pneumococcal ë°±ì‹ ì„ ì•ˆ ë§ì€ ê²½ìš° (ì„¸ê· ì„± ë‡Œìˆ˜ë§‰ì—¼ ìœ„í—˜ â†‘)\n    - Petechial rash\n    - **Antibiotics use:** ì´ë¯¸ í•­ìƒì œë¥¼ ì“°ê³  ìˆì–´ì„œ ì¦ìƒì´ ê°€ë ¤ì§„ ê²½ìš° (Masked symptoms).\n---\n## **RAPID FIRE RECAP: Scenario Testing** ğŸ”«ğŸ”¥\në§ˆì§€ë§‰ìœ¼ë¡œ ë°°ìš´ ë‚´ìš©ì„ ì‹œë‚˜ë¦¬ì˜¤ë¡œ ì •ë¦¬í•´ ë´…ì‹œë‹¤! (Audio Recap Section)\n| **Scenario** | **Diagnosis** | **Key Management/Next Step** |\n| --- | --- | --- |\n| **#1** 6ê°œì›” ì˜ì•„, Jackknife spasms (ëª¸ì„ ì ‘ìŒ) | **Infantile Spasms (West Syndrome)** | **Tx: ACTH** (Start ASAP to save brain!) |\n| **#2** 10ëŒ€ ì²­ì†Œë…„, ì•„ì¹¨ì— ì¹«ì†”ì„ ë–¨ì–´ëœ¨ë¦¼ (Morning jerks) | **Juvenile Myoclonic Epilepsy (JME)** | **Tx: Valproic Acid** (Look for sleep/alcohol triggers) |\n| **#3** 3ì„¸ ìœ ì•„, ë°œì‘ í›„ ì™¼ìª½ íŒ”ë‹¤ë¦¬ê°€ ì¶• ëŠ˜ì–´ì§ (Limp) | **Potential Stroke** (Todd's ParalysisëŠ” ë°°ì œ ì§„ë‹¨!) | **Dx: MRI Brain + MRA** (Urgent!)\nì–´ë¦°ì• ë“¤ì€ í˜ˆë¥˜ë¬¸ì œ í™•ì¸í•˜ê¸° ìœ„í•´ì„œ ì˜ìƒ ê²€ì‚¬í•œë‹¤. (Todd ì˜ì‹¬ë˜ì–´ë„) |\n| **#4** 30ì£¼ ë¯¸ìˆ™ì•„, ì‹ ìƒì•„ì‹¤(NICU) ì…ì› ì¤‘ (ì¦ìƒ ì—†ìŒ) | **IVH Risk** (Germinal Matrix Bleed) | **Screening: Head Ultrasound** at <32 weeks |\n| **#5** 3ì„¸, ì—´ë‚˜ê³  5ë¶„ê°„ ì „ì‹  ê²½ë ¨, ê¸ˆë°© ê¹¨ì–´ë‚¨ | **Simple Febrile Seizure** | **Tx: Discharge with Reassurance** (ì§‘ì— ê°€ì„¸ìš” ğŸ‘‹) |\n---\n    - ì˜¤ë””ì˜¤ì—ì„œëŠ” 32ì£¼ ë¯¸ë§Œì„ IVH ìŠ¤í¬ë¦¬ë‹ ê¸°ì¤€ìœ¼ë¡œ ì œì‹œí–ˆì§€ë§Œ, ì‹¤ì œ ì„ìƒ ê°€ì´ë“œë¼ì¸ì€ ê¸°ê´€ë§ˆë‹¤ ì•½ê°„ ë‹¤ë¥¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤ (ë³´í†µ <30-32ì£¼).\n    - Todd's ParalysisëŠ” ì ˆëŒ€ \"ì¶”ì •\"í•˜ì§€ ë§ê³  Strokeë¥¼ ë¨¼ì € R/O(ë°°ì œ) í•´ì•¼ í•œë‹¤ëŠ” ì ì´ ê°€ì¥ ì¤‘ìš”í•©ë‹ˆë‹¤.\n    - ì†Œì•„ Strokeì˜ ì›ì¸ ì¤‘ Sickle Cell DiseaseëŠ” í•œêµ­ì¸ì—ê²Œ ë“œë¬¼ì§€ë§Œ USMLEì—ì„œëŠ” ë§¤ìš° ì¤‘ìš”í•œ Key factorì…ë‹ˆë‹¤.\n# ğŸ¥ USMLE Step 2 CK Deep Dive: Critical Care, Environmental & Anesthesia ğŸš€\n### ğŸ“‹ Overview (TL;DR)ã…‹\nì˜¤ëŠ˜ì˜ Deep DiveëŠ” **Critical Care Neurology(ì¤‘í™˜ì ì‹ ê²½í•™)**, **Environmental Injuries(í™˜ê²½ ì‘ê¸‰)**, ê·¸ë¦¬ê³  **Anesthesia Complications(ë§ˆì·¨ í•©ë³‘ì¦)**ì„ ë‹¤ë£¹ë‹ˆë‹¤. USMLEì—ì„œ ì‚¬ë‘í•˜ëŠ” \"High-Stakes\" ì£¼ì œë“¤ë¡œ, ìƒëª…ì„ ìœ„í˜‘í•˜ëŠ” ìƒí™©ì—ì„œì˜ **Rapid Decision Making**ì´ í•µì‹¬ì…ë‹ˆë‹¤.\n- **Neuro Critical Care:** Sympathetic Storming (PSH), Brain Death Criteria, PICS.\n- **Environmental:** Heat Stroke (Classic vs. Exertional), Hypothermia Management.\n- **Anesthesia:** Malignant Hyperthermia, Epidural Complications, Succinylcholine Risks.\n---","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-291","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"### ğŸŒ³ Meta-Cognitive Top-Down Classification\nì˜í•™ì  ë§¥ë½ì„ êµ¬ì¡°í™”í•˜ê¸° ìœ„í•œ ê³„ì¸µí˜• íŠ¸ë¦¬ì…ë‹ˆë‹¤. ì˜¤ëŠ˜ì˜ ì£¼ì œê°€ ì–´ë””ì— ìœ„ì¹˜í•˜ëŠ”ì§€ í™•ì¸í•˜ì„¸ìš”!\nPlaintext\n`CRITICAL CARE & EMERGENCY MEDICINE\nâ”‚\nâ”œâ”€â”€ ğŸ§  Neuro Critical Care\nâ”‚   â”œâ”€â”€ Hyperactive State\nâ”‚   â”‚   â””â”€â”€ Paroxysmal Sympathetic Hyperactivity (PSH) \"Storming\"\nâ”‚   â”œâ”€â”€ Loss of Function\nâ”‚   â”‚   â”œâ”€â”€ Brain Death (Irreversible)\nâ”‚   â”‚   â””â”€â”€ Coma (Potentially Reversible)\nâ”‚   â””â”€â”€ Chronic Sequelae\nâ”‚       â””â”€â”€ Post-Intensive Care Syndrome (PICS)\nâ”‚\nâ”œâ”€â”€ ğŸŒ¡ï¸ Environmental Injuries (Thermoregulation Failure)\nâ”‚   â”œâ”€â”€ Hyperthermia (Heat)\nâ”‚   â”‚   â”œâ”€â”€ Heat Exhaustion (CNS Intact)\nâ”‚   â”‚   â””â”€â”€ Heat Stroke (CNS Dysfunction)\nâ”‚   â”‚       â”œâ”€â”€ Classic (Non-exertional, Elderly)\nâ”‚   â”‚       â””â”€â”€ Exertional (Athletes)\nâ”‚   â””â”€â”€ Hypothermia (Cold)\nâ”‚       â”œâ”€â”€ Mild (Shivering)\nâ”‚       â”œâ”€â”€ Moderate (No shivering)\nâ”‚       â””â”€â”€ Severe (Coma/Arrhythmia)\nâ”‚\nâ””â”€â”€ ğŸ’‰ Anesthesia Complications\n    â”œâ”€â”€ Hypermetabolic Crisis\n    â”‚   â””â”€â”€ Malignant Hyperthermia (MH)\n    â”œâ”€â”€ Neuraxial Complications\n    â”‚   â”œâ”€â”€ Post-dural Puncture Headache\n    â”‚   â””â”€â”€ High Spinal (Resp. Paralysis)\n    â””â”€â”€ Drug Specific\n        â””â”€â”€ Succinylcholine Induced Hyperkalemia`\n---\n# 1. Neuro Critical Care: The \"Storm\" & The \"Silence\" ğŸ§ âš¡ï¸\n### ğŸšª Doorway Thought: Clinical Vignette\në‘ ëª…ì˜ í™˜ìê°€ ìˆìŠµë‹ˆë‹¤. ë‘˜ ë‹¤ **Autonomic Explosion** ìƒíƒœì²˜ëŸ¼ ë³´ì…ë‹ˆë‹¤.\n1. **Patient A (ICU):** ì‹¬ê°í•œ TBI(Traumatic Brain Injury) í›„ íšŒë³µ ì¤‘. ê°„í˜¸ì‚¬ê°€ ë‹¨ìˆœíˆ ìŠ¤í€ì§€ ëª©ìš•(Sponge bath)ì„ ì‹œí‚¤ëŠ”ë° ê°‘ìê¸° ì‹¬ë°•ìˆ˜ ê¸‰ì¦, í˜ˆì•• ìƒìŠ¹, ê³ ì—´, ì‹ì€ë•€ì´ ë¹„ ì˜¤ë“¯ ìŸì•„ì§.\n2. **Patient B (OR):** ìˆ˜ìˆ ì„ ìœ„í•´ ë§‰ ì‚½ê´€(Intubation)í•¨. ê°‘ìê¸° í„± ê·¼ìœ¡(Jaw muscle)ì´ ëŒì²˜ëŸ¼ êµ³ê³ (Clamped shut), í™˜ê¸°(Ventilation)ê°€ ì˜ ë˜ëŠ”ë°ë„ í˜¸ê¸°ë§ ì´ì‚°í™”íƒ„ì†Œ(ETCO2)ê°€ ë¯¸ì¹œ ë“¯ì´ ì¹˜ì†ŸìŒ.\nğŸ‘‰ **Diagnosis?**\n- Patient A: **Paroxysmal Sympathetic Hyperactivity (PSH)** a.k.a \"Storming\"\n- Patient B: **Malignant Hyperthermia (MH)**\n---\n## 1-1. Paroxysmal Sympathetic Hyperactivity (PSH)\n- **Concept:** TBI ë“±ìœ¼ë¡œ ì¸í•´ Cortical inhibition(ëŒ€ë‡Œì˜ ì œì–´)ì´ ëŠì–´ì§„ ìƒíƒœ. Brainstem(ë‡Œê°„)ì˜ Fight or Flight ì„¼í„°ê°€ ë¸Œë ˆì´í¬ ì—†ì´ í­ì£¼í•˜ëŠ” ê²ƒ.\n- **Trigger:** í†µì¦ì´ ì—†ëŠ” ìê·¹(Non-painful stimuli)ì´ íŠ¸ë¦¬ê±°ê°€ ë¨.\n    - ì˜ˆ: ëª©ìš•(Bathing), ì²´ìœ„ ë³€ê²½(Turning), ê°€ë˜ í¡ì…(Suctioning).\n- **Signs (Cluster of 5):**\n    1. Tachycardia (ë¹ˆë§¥)\n    2. Hypertension (ê³ í˜ˆì••)\n    3. Tachypnea (ë¹ˆí˜¸í¡)\n    4. Fever (ê³ ì—´)\n    5. Diaphoresis (ë°œí•œ)\n    - *Note:* 20~30ë¶„ ì •ë„ ì§€ì†ë¨. ë‹¨ìˆœí•œ ê³µí¬ ë°˜ì‘(Scare)ì´ ì•„ë‹˜.\n### ğŸ’Š Management\ní™”í•™ì  ì¥ë²½(Chemical Barrier)ì„ ë‹¤ì‹œ ì„¸ì›Œì¤˜ì•¼ í•©ë‹ˆë‹¤.\n- **Goal:** Replace the inhibition.\n- **Medications:**\n    - **Opioids:** í†µì¦ ì¡°ì ˆ ë° ì§„ì •.\n    - **GABA Agonists:** **Baclofen** (ì–µì œì„± ì‹ í˜¸ ê°•í™”).\n    - **Alpha-2 Agonists:** **Clonidine**, **Dexmedetomidine** (êµê°ì‹ ê²½ ìœ ì¶œ ì°¨ë‹¨).","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-311","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"---\n## 1-2. Post-Intensive Care Syndrome (PICS) ğŸ“‰\nICU ìƒì¡´ì˜ ëŒ€ê°€(Price of survival). í‡´ì› í›„ baselineìœ¼ë¡œ ëŒì•„ê°€ì§€ ëª»í•˜ëŠ” í˜„ìƒ.\n- **The 3 Domains (Rule of 50s - 50% ì´ìƒì˜ ìƒì¡´ìê°€ ê²ªìŒ):**\n    1. **Psychiatric:** Major Depression, PTSD.\n    2. **Neurocognitive:** Dementia-like deficits (ê¸°ì–µë ¥, ì§‘ì¤‘ë ¥ ì €í•˜, ì‹¤í–‰ ê¸°ëŠ¥ ì¥ì• ). ì›ì¸ì€ CNS hypoxia, neuro-inflammation ë“±.\n    3. **Physical:** \"ICU Acquired Weakness\" (ê·¼ìœ¡ ìœ„ì¶•, ê±°ë™ ëŠ¥ë ¥ ìƒì‹¤).\n### ğŸ›¡ï¸ Prevention: ICU Liberation Strategies (Gold Standard) â˜…\nê¸°ì°¨(PICS Train)ê°€ ì˜¤ëŠ” ê²ƒì„ ë§‰ì•„ì•¼ í•©ë‹ˆë‹¤.\n- **Physical:** **Early PT/Mobilization** (ì•ˆì „í•˜ìë§ˆì ë°”ë¡œ ì›€ì§ì´ê²Œ í•¨).\n- **Pharmacological:** Deliriumì„ ìœ ë°œí•˜ëŠ” ì•½ë¬¼ ìµœì†Œí™”.\n- **Protocol:**\n    - **SAT (Spontaneous Awakening Trial):** ë§¤ì¼ ì§„ì •ì œë¥¼ êº¼ì„œ ê¹¨ì›Œë´„.\n    - **SBT (Spontaneous Breathing Trial):** ë§¤ì¼ ìë°œ í˜¸í¡ ëŠ¥ë ¥ì„ í…ŒìŠ¤íŠ¸í•¨.\n    - ë‡Œë¥¼ ê³„ì† \"Engage\" ì‹œí‚¤ëŠ” ê²ƒì´ í•µì‹¬!\n---\n# 2. Brain Death: The Final Diagnosis ğŸ’€\n**Brain Death vs. Cardiac Death:**\n- Cardiac Death: ì‹¬ì¥ì´ ë©ˆì¶¤.\n- Brain Death: ë‡Œê°„(Brainstem)ê¹Œì§€ ì™„ì „íˆ ê¸°ëŠ¥ ì •ì§€. ì‹¬ì¥ì€ ì¸ê³µí˜¸í¡ê¸° ë•ë¶„ì— ëœ€.\n### ğŸ›‘ Prerequisites (Before you confirm)\ní™˜ìì—ê²Œ ì†ì„ ëŒ€ê¸° ì „ì— í™•ì¸í•´ì•¼ í•  ê²ƒë“¤:\n1. **Known Irreversible Cause:** (ì˜ˆ: Massive TBI, Anoxic injury). ë¯¸ìŠ¤í„°ë¦¬ í™˜ìì—ê²Œ ë‡Œì‚¬ ì„ ì–¸ ë¶ˆê°€.\n2. **Body Capable of Response:**\n    - Temp > 36Â°C (ì €ì²´ì˜¨ì¦ ë°°ì œ).\n    - SBP > 100 mmHg (ì‡¼í¬ ìƒíƒœ ë°°ì œ).\n    - No Electrolyte/Metabolic issues.\n    - No Paralytics/Sedatives on board.\n### ğŸ”¨ The Exam (Brainstem Reflexes)\nTop-to-Bottomìœ¼ë¡œ ë‡Œê°„ ë°˜ì‚¬ê°€ **ëª¨ë‘ ì†Œì‹¤(Absent)**ë˜ì–´ì•¼ í•¨.\n- Pupils: Fixed & Dilated (Non-reactive).\n- Corneal Reflex: Absent.\n- Oculo-vestibular (Cold Caloric/Doll's eyes): Absent.\n- Gag/Cough: Absent.\n- **Motor Response:** **No Brain-originating motor response.**\n    - âš ï¸ **HUGE TRAP:** **Spinal Reflexes** (Deep tendon reflex, ë¬´ë¦ ì¹˜ë©´ ë°˜ì‘í•˜ëŠ” ê²ƒ)ëŠ” ë‚¨ì•„ìˆì„ ìˆ˜ ìˆìŒ! ë‡Œê°€ ê´€ì—¬í•˜ì§€ ì•ŠëŠ” ì²™ìˆ˜ ë°˜ì‚¬ì´ê¸° ë•Œë¬¸. í™˜ìì˜ ì†ì„ ë§Œì¡ŒëŠ”ë° ì›€ì°”í•œë‹¤ê³  í•´ì„œ ë‡Œì‚¬ê°€ ì•„ë‹ˆë¼ê³  íŒë‹¨í•˜ë©´ ì•ˆ ë¨(Lazarus sign ë“±).\n### ğŸŒ¬ï¸ The Apnea Test (The Definitive Test / Gold Standard) â˜…\nê°€ì¥ ì›ì´ˆì ì¸ ë‡Œê°„ ê¸°ëŠ¥ì¸ \"í˜¸í¡ ë“œë¼ì´ë¸Œ(Drive to breathe)\"ë¥¼ í…ŒìŠ¤íŠ¸í•¨.\n1. **Pre-oxygenate:** ì‚°ì†Œë¥¼ ì¶©ë¶„íˆ ì¤Œ.\n2. **Disconnect Ventilator:** í˜¸í¡ê¸°ë¥¼ ë—Œ.\n3. **Wait:** 8~10ë¶„ ê´€ì°°.\n4. **Positive Criteria (Brain Death Confirmed):**\n    - **No Respiratory Effort** (ê°€ìŠ´ ì›€ì§ì„ ì—†ìŒ).\n    - **PaCO2 > 60 mmHg** (í˜¹ì€ ë² ì´ìŠ¤ë¼ì¸ë³´ë‹¤ 20 ì´ìƒ ìƒìŠ¹).\n    - **pH < 7.28** (Acidosis).\n- *Note:* í™˜ìê°€ ë¶ˆì•ˆì •í•´ì„œ Apnea testë¥¼ ëª»í•˜ë©´? **Ancillary Tests** (EEG Flatline, Cerebral Angiography - No flow) ì‚¬ìš©.","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-331","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","diagnosis","tree"]}
{"chunk_type":"transcript_chunk","text":"### â¤ï¸ Organ Donation Physiology\në‡Œì‚¬ í›„ ì‹ ì²´ëŠ” ë¶•ê´´(Collapse)í•˜ê¸° ì‹œì‘í•¨. ì¥ê¸° ê¸°ì¦ì„ ìœ„í•´ ê¸°ëŠ¥ì„ ìœ ì§€í•´ì•¼ í•¨.\n1. **Diabetes Insipidus (DI):** ë‡Œí•˜ìˆ˜ì²´ í›„ì—½ ì‚¬ë§ â†’ ADH ì•ˆ ë‚˜ì˜´ â†’ ì†Œë³€ í­ë°œ(ì‹œê°„ë‹¹ 1Lì”©).\n    - ğŸ‘‰ **Tx:** Desmopressin, Massive Fluids.\n2. **Systemic Hypotension:** êµê°ì‹ ê²½ í†¤ ìƒì‹¤ â†’ í˜ˆê´€ í™•ì¥.\n    - ğŸ‘‰ **Tx:** Pressors, Fluids.\n3. **Hypothermia:** ì‹œìƒí•˜ë¶€(Thermostat) ì‚¬ë§.\n    - ğŸ‘‰ **Tx:** Warming blankets (Active external warming).\n---\n# 3. Environmental Injuries: Heat & Cold ğŸŒ¡ï¸\n## 3-1. Heat Stroke vs. Heat Exhaustion ğŸ”¥\nê¸°ì¤€ì : **Core Temp 40Â°C (104Â°F)** + **CNS Dysfunction (Mental Status)**\n| **Feature** | **Heat Exhaustion** | **Heat Stroke (Emergency!)** |\n| --- | --- | --- |\n| **Temperature** | < 40Â°C | **> 40Â°C** |\n| **CNS Status** | **Normal** (ì§œì¦ë‚¼ ìˆœ ìˆì–´ë„ í˜¼ëˆì€ ì—†ìŒ) | **Confused, Seizure, Coma** |\n| **Treatment** | Fluids, Cool environment | **Rapid Cooling** (See below) |\n### â„ï¸ Heat Stroke Types & Management (High Yield!)\në‘ ê°€ì§€ íƒ€ì…ì˜ ì¹˜ë£Œë²•ì´ ë‹¤ë¥´ë‹¤ëŠ” ê²ƒì´ ì‹œí—˜ í¬ì¸íŠ¸!\n1. **Classic (Non-exertional):**\n    - **Who:** í• ë¨¸ë‹ˆ(Elderly), í•­ì½œë¦°ì„± ì•½ë¬¼ ë³µìš©ì(ë•€ ì•ˆ ë‚¨).\n    - **Skin:** **Dry** & Hot.\n    - **Tx:** **Evaporative Cooling** (ë¯¸ì§€ê·¼í•œ ë¬¼ ë¿Œë¦¬ê³  ì„ í’ê¸° í‹€ê¸°).\n        - âš ï¸ **Warning:** **Ice Water Immersion ê¸ˆì§€!** ë…¸ì¸ì€ ì°¬ë¬¼ì— ë“¤ì–´ê°€ë©´ í˜ˆê´€ ìˆ˜ì¶•(Vasoconstriction)ìœ¼ë¡œ ì—´ì„ ê°€ë‘ê³ , ì˜¤í•œ(Shivering)ìœ¼ë¡œ ì—´ì„ ë” ìƒì‚°í•˜ì—¬ ì‚¬ë§ë¥ ì´ ì˜¬ë¼ê°.\n2. **Exertional:**\n    - Heat exhaustionê³¼ Exertional heat strokeê³¼ì˜ ì°¨ì´ì :\n        - *ì˜ì‹ì´ ì†Œì‹¤ë˜ì–´ìˆê³ , ì²´ì˜¨ì´ 40ë„ ì´ìƒì„.*\n    - **Who:** ìš´ë™ì„ ìˆ˜, êµ°ì¸, ìœ¡ì²´ë…¸ë™ì.\n    - **Skin:** **Sweating** profusley (ëŒ€ì‚¬ì„± ì—´ ìƒì‚°).\n    - **Tx:** **Ice Water Immersion** (ì–¼ìŒë¬¼ì— ë‹´ê·¸ê¸°). ì Šê³  ê±´ê°•í•´ì„œ ì „ë„(Conduction) ëƒ‰ê°ì´ ê°€ì¥ ë¹ ë¥´ê³  íš¨ê³¼ì .\n## 3-2. Hypothermia ğŸ¥¶\n- **Mild (32-35Â°C):** ì˜¤í•œ(Shivering) ìˆìŒ.\n    - ğŸ‘‰ **Tx:** **Passive External Rewarming** (ë‹´ìš” ë®ê¸°, ì –ì€ ì˜· ì œê±°).\n- **Moderate (28-32Â°C):** ì˜¤í•œ ë©ˆì¶¤(ì—ë„ˆì§€ ê³ ê°ˆ), ê¸°ë©´(Lethargic).\n    - ğŸ‘‰ **Tx:** **Active External Rewarming** (ì˜¨ì—´ íŒ¨ë“œ, ë”°ëœ»í•œ ëª©ìš•).\n- **Severe (<28Â°C):** í˜¼ìˆ˜(Coma), ì‹¬ì‹¤ì„¸ë™(V-fib) ìœ„í—˜.\n    - ğŸ‘‰ **Tx:** **Active Internal Rewarming** (Warm IV fluids, Warm Lavage - Bladder/Peritoneal, ECMO). \"Core\"ë¶€í„° ë°ì›Œì•¼ í•¨.\n    - ì €ì²´ì˜¨ì¦ bradycardiaì—ì„œëŠ” atropineë“±ì´ íš¨ê³¼ê°€ ì—†ìŒ. (pacemakerê°€ ì–¼ì–´ìˆìŒ.)\n    â†’ ì•½ ëŒ€ì‹  ì²´ì˜¨ì„ ë¨¼ì € ì˜¬ë ¤ì¤˜ì•¼í•¨.\n- Frostbite:\n    - pallor skin, anesthesia, blistering, necrosis\n    - Management:\n        - water bath\n        - rewarming\n        - **Refreezing Risk:** ë™ìƒ(Frostbite) ë¶€ìœ„ê°€ ë‹¤ì‹œ ì–¼ ê°€ëŠ¥ì„±ì´ ìˆë‹¤ë©´ ì ˆëŒ€ ë…¹ì´ì§€ ë§ˆë¼(Thaw). ì¡°ì§ ê´´ì‚¬ê°€ í›¨ì”¬ ì‹¬í•´ì§. â˜…\n---\n# 4. Anesthesia Complications ğŸ˜·\n## 4-1. Malignant Hyperthermia (MH) ğŸ”¥\n- **Genetic:** Ryanodine Receptor ë³€ì´ (Autosomal Dominant).\n- **Trigger:** **Volatile Anesthetics** (Halothane, Sevoflurane ë“±) + **Succinylcholine**.\n- **Pathophysiology:** ê·¼ìœ¡ ì„¸í¬ ë‚´ ì¹¼ìŠ˜(Ca2+) í†µì œ ë¶ˆëŠ¥ â†’ ê·¼ìœ¡ ìˆ˜ì¶• ì§€ì† â†’ ëŒ€ì‚¬ í­ë°œ.\n- **Signs:**\n    - **Early:** Masseter Muscle Rigidity (í„± ê·¼ìœ¡ ê°•ì§), **Rising ETCO2** (í™˜ê¸° ì˜ ë˜ëŠ”ë°ë„ CO2 ìƒìŠ¹ - ì´ì‚°í™”íƒ„ì†ŒëŠ” ëŒ€ì‚¬ ì‚°ë¬¼ì„).\n    - **Late:** Hyperthermia (ì—´ì€ ë‚˜ì¤‘ì— ë‚¨), Rhabdomyolysis, Hyperkalemia.\n- **Tx (Gold Standard):** â˜…\n    1. **Stop Trigger** immediately.\n    2. **Dantrolene** IV (RyR antagonist - ê·¼ìœ¡ ì´ì™„).\n## 4-2. Succinylcholine Risks â˜ ï¸\n- **Mechanism:** Depolarizing blocker. ìˆ˜ìš©ì²´ì— ë¶™ì–´ì„œ íƒˆë¶„ê·¹(Depolarization)ì„ ì‹œí‚´. ì´ ê³¼ì •ì—ì„œ ì„¸í¬ ë‚´ **K+ (ì¹¼ë¥¨)**ì´ ë°–ìœ¼ë¡œ ì¡°ê¸ˆ ë‚˜ì˜´.\n- **Contraindications:** **Upregulation of ACh Receptors**ê°€ ìˆëŠ” í™˜ìë“¤.\n    - Burn victims (í™”ìƒ), Crush injury, Stroke/Denervation, Guillain-Barre.\n    - ì´ í™˜ìë“¤ì€ ê·¼ìœ¡ ì „ì²´ì— ìˆ˜ìš©ì²´ê°€ ê¹”ë ¤ìˆì–´ì„œ Suxë¥¼ ì“°ë©´ K+ê°€ ëŒ€ëŸ‰ ë°©ì¶œë¨ â†’ **Cardiac Arrest**.\n    - ğŸ‘‰ **Next Best Step:** **Rocuronium** or **Vecuronium** (Non-depolarizing) ì‚¬ìš©.","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-351","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"## 4-3. Neuraxial Anesthesia (Epidural/Spinal)\n- **Hypotension:** êµê°ì‹ ê²½ ì°¨ë‹¨(Sympathetic blockade) â†’ í˜ˆê´€ í™•ì¥. (m/c complication).\n- **High Spinal:** ë§ˆì·¨ì œê°€ ë„ˆë¬´ ë†’ê²Œ ì˜¬ë¼ê°€ì„œ C3-C5(íš¡ê²©ë§‰) ë§ˆë¹„ â†’ Respiratory Arrest. (ìƒì§€ì˜ í˜ì´ ì•½í•´ì§€ë©´ ì˜ì‹¬..)\n- **Post-dural Puncture Headache:** ë°”ëŠ˜ì´ Duraë¥¼ ëš«ìŒ â†’ CSF ëˆ„ì¶œ.\n    - íŠ¹ì§•: ì„œ ìˆìœ¼ë©´(Upright) ì•„í”„ê³  ëˆ„ìš°ë©´(Supine) ì¢‹ì•„ì§.\n    - ğŸ‘‰ **Tx:** **Epidural Blood Patch** (ë³¸ì¸ í”¼ë¥¼ ì£¼ì…í•´ì„œ êµ¬ë©ì„ ë§‰ìŒ).\n---\n### ğŸ”¥ Rapid Fire Recap (Summary Table)\n| **Condition** | **Key Trigger/Sign** | **Gold Standard / Next Best Step â˜…** |\n| --- | --- | --- |\n| **PSH (Storming)** | TBI + Non-painful trigger (Bath) | **Opioids, Baclofen, Clonidine** (Replace inhibition) |\n| **Malignant Hyperthermia** | Volatiles/Sux + Jaw Rigidity + â†‘ETCO2 | **Stop Agent + Dantrolene** |\n| **Brain Death** | Absent Reflexes + Apnea | **Apnea Test** (PaCO2 > 60, No breath) |\n| **Classic Heat Stroke** | Grandma, Dry skin, >40Â°C | **Evaporative Cooling** (Mist + Fan) *NO ICE BATH* |\n| **Exertional Heat Stroke** | Athlete, Sweating, >40Â°C | **Ice Water Immersion** |\n| **Hypothermia (Severe)** | < 28Â°C, Coma/Arrhythmia | **Active Internal Rewarming** (Lavage/ECMO) |\n| **PDPH (Headache)** | Better when lying flat | **Epidural Blood Patch** |","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-371","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","treatment"]}
{"chunk_type":"transcript_chunk","text":"# LM_neuro 4\n### ğŸ“‹ Overview: Ophthalmology Infections (USMLE Step 2 CK)\n**TL;DR Summary Table**\n| **Category** | **Key Pathology** | **Classic Sign / Keyword** | **Immediate Action / Tx** |\n| --- | --- | --- | --- |\n| **Orbit** | Orbital Cellulitis | Pain with EOM, Proptosis, Ophthalmoplegia | **â˜… CT Scan + IV Abx + Surgery** |\n|  | Preseptal Cellulitis | Eyelid swelling ONLY (No pain with EOM) | Oral Antibiotics |\n| **Conjunctiva** | Viral Conjunctivitis | Watery, gritty, follicular | Supportive / Hygiene |\n|  | Bacterial Conjunctivitis | Purulent, \"glued shut\", unremitting | Erythromycin or Polytrim drops |\n|  | Neonatal (Gonococcal) | Day 2-5, Profuse Purulent, Corneal risk | **â˜… IM Ceftriaxone (Systemic)** |\n|  | Neonatal (Chlamydia) | Day 5-14, Pneumonia risk | **â˜… Oral Erythromycin (Systemic)** |\n| **Cornea** | HSV Keratitis | Dendritic Ulcer, decreased sensation | Acyclovir / Ganciclovir |\n|  | Bacterial Keratitis | Contact lens, Pseudomonas | Fluoroquinolone Drops |\n| **Intraocular** | Endophthalmitis | Post-Cataract, Hypopyon, Vitreous Haze | **â˜… Intravitreal Abx + Vitrectomy** |\n|  | Anterior Uveitis | Photophobia, Ciliary Flush, HLA-B27 | Steroids + Cycloplegics |\n---\n### ğŸŒ³ Top-Down Classification: Eye Infections\nUSMLEì—ì„œ ì•ˆê³¼ ê°ì—¼ì€ **\"Anatomical Depth (í•´ë¶€í•™ì  ê¹Šì´)\"**ì™€ **\"Mechanism (ê¸°ì „)\"**ì— ë”°ë¼ ë¶„ë¥˜ë©ë‹ˆë‹¤.\nPlaintext\n#\n`EYE INFECTIONS (Hierarchy of Depth)\nâ”‚\nâ”œâ”€â”€ 1. Eyelid & Lacrimal (Surface \"Lumps & Bumps\")\nâ”‚   â”œâ”€â”€ Hordeolum (Stye): Painful, Acute Infection (Staph)\nâ”‚   â”œâ”€â”€ Chalazion: Painless, Chronic Granuloma\nâ”‚   â”œâ”€â”€ Blepharitis: \"Dandruff\" of eyelashes\nâ”‚   â”œâ”€â”€ Dacryocystitis: Infected Lacrimal Sac (Medial Canthus)\nâ”‚   â””â”€â”€ Nasolacrimal Duct Stenosis: \"Wet Eye\" only (No Redness)\nâ”‚\nâ”œâ”€â”€ 2. Orbital vs. Preseptal (The \"Wall\")\nâ”‚   â”œâ”€â”€ Preseptal Cellulitis: Anterior to Septum (Skin deep)\nâ”‚   â””â”€â”€ Orbital Cellulitis: Posterior to Septum (DANGER! Brain proximity)\nâ”‚\nâ”œâ”€â”€ 3. Conjunctiva (The \"White part\")\nâ”‚   â”œâ”€â”€ Viral: Pink, Watery (Adenovirus)\nâ”‚   â”œâ”€â”€ Bacterial: Purulent, Glued shut\nâ”‚   â”œâ”€â”€ Allergic: Itching, Bilateral\nâ”‚   â””â”€â”€ Neonatal: Time-dependent (Chemical â†’ GC â†’ Chlamydia)\nâ”‚\nâ”œâ”€â”€ 4. Cornea (The \"Window\")\nâ”‚   â”œâ”€â”€ HSV Keratitis: Dendritic\nâ”‚   â”œâ”€â”€ Bacterial Keratitis: Contact Lens (Pseudomonas)\nâ”‚   â””â”€â”€ Fungal Keratitis: Vegetable matter, Feathery\nâ”‚\nâ””â”€â”€ 5. Intraocular (Deep Inside)\n    â”œâ”€â”€ Anterior Uveitis: Iris/Ciliary body (Autoimmune/HLA-B27)\n    â””â”€â”€ Endophthalmitis: Vitreous Humor (Post-surgery Nightmare)`\n### Orbital cellulitis ìª½ì´ë©´ ê±°ì˜ ë¬´ì¡°ê±´ â€œì•ˆêµ¬/ì•ˆì™€ ê¸°ëŠ¥ ì¥ì• â€ê°€ ëœ¸â˜…\n- **Pain with eye movementâ˜…**\n- **Ophthalmoplegia / diplopiaâ˜…**\n- **Proptosisâ˜…**\n- **Vision change / RAPDâ˜…**\n- Â± fever, toxic\n### Preseptal cellulitisëŠ” â€œëˆˆêº¼í’€ë§Œâ€ í¬ê²Œ ì•„í”„ê³  ë¶“ëŠ”ë°â˜…\n- **ì‹œë ¥ ì •ìƒ**\n- **EOM ì •ìƒ**, pain with movement ì—†ìŒ\n- **proptosis ì—†ìŒ**\n### ConjunctivitisëŠ” ì£¼ë¡œ\n- **ê²°ë§‰ ì¶©í˜ˆ + ë¶„ë¹„ë¬¼ + ì´ë¬¼ê°**\n- **ì‹œë ¥ì€ ëŒ€ì²´ë¡œ ì •ìƒ(ì‹¬í•œ photophobia/ì‹œë ¥ì €í•˜ë©´ ê°ë§‰ ë³‘ë³€ ì˜ì‹¬)**\n---","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-1","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"### 1. Orbital vs. Preseptal Cellulitis (The Heavyweight Championship) ğŸ¥Š\n**ğŸšª Vignette Anchors:**\n- **Scenario A (Orbital):** 5ì„¸ ì•„ì´, ë¹„ëª…ì„ ì§€ë¦„(Screaming), ëˆˆì„ ë§Œì§€ì§€ë„ ëª»í•˜ê²Œ í•¨, ëˆˆì„ ëœ° ë•Œ ê·¹ì‹¬í•œ ê³ í†µ.\n- **Scenario B (Preseptal):** í‹±í†¡ ë³´ê³  ìˆëŠ” 10ëŒ€, ëˆˆì´ ë¶“ê³  ëˆì í•˜ì§€ë§Œ(Sticky), ì¹¨ì°©í•¨(Calm). ì¢€ ê·€ì°®ì•„í•  ë¿ ê³ í†µìŠ¤ëŸ¬ì›Œí•˜ì§€ ì•ŠìŒ.\n![image.png](LM_neuro%204/image.png)\n### ğŸ§  Concept & Anatomy: The Orbital Septum\n- **Orbital Septum:** ëˆˆêº¼í’€ì˜ ë¼ˆ(Rim)ì—ì„œ ëˆˆêº¼í’€(Eyelid)ë¡œ ë‚´ë ¤ì˜¤ëŠ” ì„¬ìœ ì„± ì¡°ì§(Fibrous tissue).\n    - **ì—­í• :** \"Firewall\" (ë°©í™”ë²½) ë˜ëŠ” \"Bulkhead\" (ê²©ë²½) ì—­í• . ë°”ê¹¥ì„¸ìƒ(í”¼ë¶€)ê³¼ ì•ˆìª½ ì„¸ìƒ(Orbit: ì•ˆêµ¬, ì§€ë°©, ê·¼ìœ¡, ì‹œì‹ ê²½, ë‡Œë¡œ ê°€ëŠ” í†µë¡œ)ì„ ë¶„ë¦¬í•¨.\n- **ì§€ë¦¬ì  ìœ„ì¹˜(Geography)ê°€ ì§„ë‹¨ì„ ê²°ì •í•¨:**\n    - **Preseptal:** Septum ì•ìª½ í”¼ë¶€ ê°ì—¼ (Eye machineryëŠ” ì•ˆì „í•¨).\n    - **Orbital:** ì„¸ê· ì´ ë°©í™”ë²½ì„ ëš«ìŒ. ì•ˆêµ¬ ë’¤ìª½ì˜ ì§€ë°©ê³¼ ê·¼ìœ¡ì— ê°ì—¼. **Surgical Emergency!**\n### ğŸš‘ The Deadly Trio (Signs of Orbital Cellulitis)\nì‹œí—˜ì—ì„œ ì´ 3ê°€ì§€ ì¤‘ í•˜ë‚˜ë¼ë„ ë³´ì´ë©´ **ë¬´ì¡°ê±´ Orbital**ì…ë‹ˆë‹¤. (Preseptalì€ ì´ ì¦ìƒì´ ì—†ìŒ!)\n1. **Pain with Extraocular Movements (EOM):** ëˆˆì„ ì›€ì§ì¼ ë•Œë§ˆë‹¤ ì•„í”” (ì—¼ì¦ì´ ìˆëŠ” ê·¼ìœ¡ì„ ëŒì–´ë‹¹ê¸°ê¸° ë•Œë¬¸).\n2. **Proptosis (Bulging):** ì•ˆêµ¬ê°€ íŠ€ì–´ ë‚˜ì˜´ (ì•ˆêµ¬ ë’¤ìª½ ê³µê°„ì— ê³ ë¦„/ì—¼ì¦ì´ ì°¨ì„œ ëˆˆì„ ì•ìœ¼ë¡œ ë°€ì–´ëƒ„).\n3. **Ophthalmoplegia:** ëˆˆì´ ì–¼ì–´ë¶™ì–´ ì›€ì§ì´ì§€ ì•ŠìŒ (ê·¼ìœ¡ ë§ˆë¹„/ê¸°ëŠ¥ ì •ì§€).\n    - *ì¶”ê°€:* Diplopia (ë³µì‹œ), Vision loss (ì‹œì‹ ê²½ ì••ë°•).\n### ğŸ¦  Etiology\n- **Orbital CellulitisëŠ” ë‹¨ë…ìœ¼ë¡œ ì˜ ì•ˆ ìƒê¹€.**\n- ëŒ€ë¶€ë¶„ **Bacterial Rhinosinusitis (ë¶€ë¹„ë™ì—¼)**ì˜ í•©ë³‘ì¦. Ethmoid sinus(ì‚¬ê³¨ë™)ì˜ ì–‡ì€ ë¼ˆë¥¼ ëš«ê³  ê°ì—¼ì´ ì¹¨íˆ¬í•¨.\n### ğŸ’Š Management & Next Best Step\n| **Condition** | **Next Best Step (Dx)** | **Treatment (Tx)** |\n| --- | --- | --- |\n| **Preseptal** | Clinical Dx (ëˆˆ ì˜ ì›€ì§ì„) | **Oral Antibiotics** + Close Follow-up |\n| **Orbital** | **â˜… CT Scan of Orbit** | **â˜… IV Antibiotics (Vancomycin + Cephalosporin) + Surgical Drainage (if abscess)** |\n---\n### 2. Conjunctivitis (Pink Eye) ğŸ‘ï¸\n![image.png](LM_neuro%204/image%201.png)\n![image.png](LM_neuro%204/image%202.png)\n**ğŸšª Vignette Anchor:** ì–´ë¦°ì´ì§‘(Daycare)ì—ì„œ ìœ í–‰í•˜ëŠ” ëˆˆë³‘. \"Discharge(ë¶„ë¹„ë¬¼)\"ì˜ ì–‘ìƒì´ í•µì‹¬.\n### A. Viral Conjunctivitis (Most Common)\n- **Vignette:** \"Pink eye\", ë¬½ì€ ëˆˆë¬¼(Watery), ëª¨ë˜ ë“¤ì–´ê°„ ëŠë‚Œ(Gritty), ê°ê¸° ê¸°ìš´(Viral prodrome).\n- **Exam:** ëˆˆêº¼í’€ ë’¤ì§‘ì–´ë³´ë©´ **Follicular appearance** (ìŒ€ì•Œ ê°™ì€ ëŒê¸°).\n- **Cause:** **Adenovirus** (ì „ì—¼ì„± ë§¤ìš° ê°•í•¨, Self-limiting).\n- **Tx:** Supportive (ì‹œì›í•œ ì°œì§ˆ, ìœ„ìƒ ê´€ë¦¬).","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-21","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"### B. Bacterial Conjunctivitis\n- **Vignette:** \"Gross\", **Purulent (Frank Pus)**, ì•„ì¹¨ì— ëˆˆì´ ë”± ë¶™ì–´ì„œ ì•ˆ ë– ì§ (\"Glued shut\").\n- **Key Descriptor:** **\"Unremitting discharge\"** (ë‹¦ì•„ë„ ëª‡ ë¶„ ë’¤ì— ë‹¤ì‹œ ê³ ë¦„ì´ ì°¸).\n- **Tx:** Erythromycin ointment or Polytrim drops.\n    - **âš ï¸ Contact Lens Wearer:** **Pseudomonas** ìœ„í—˜! â†’ **â˜… Fluoroquinolones (Ciprofloxacin/Ofloxacin)** drops í•„ìˆ˜.\n### C. Allergic Conjunctivitis\n- **Vignette:** ëˆˆì„ ê³„ì† ë¹„ë¹”(Rubbing).\n- **Hallmark:** **Itching (ê°€ë ¤ì›€)** = Allergy. ì•ˆ ê°€ë ¤ìš°ë©´ ì•Œë ˆë¥´ê¸° ì•„ë‹˜.\n- **Exam:** Chemosis (ê²°ë§‰ë¶€ì¢… - Jelly ê°™ì€ ë¶“ê¸°), Bilateral(ì–‘ìª½).\n- **Tx:** Antihistamines.\n---\n### 3. Neonatal Conjunctivitis: The Timeline ğŸ‘¶â³\nì‹ ìƒì•„ ê²°ë§‰ì—¼ì€ **\"ìƒí›„ ë©°ì¹ ì§¸ì¸ê°€?\"**ê°€ ì§„ë‹¨ëª…ì…ë‹ˆë‹¤. (USMLE Classic)\n| **Timeline** | **Cause** | **Characteristics** | **Treatment (Tx)** |\n| --- | --- | --- | --- |\n| **Day 1 (<24hr)** | **Chemical** | Silver Nitrate/Erythromycin drops ìê·¹. Mild, non-purulent. | **Lubricant**. (Self-resolving) |\n| **Day 2-5** | **Gonococcal** (N. gonorrhea) | **ğŸ”¥ EMERGENCY.** Profuse Purulent Discharge (\"ëˆˆì´ ê³ ë¦„ìœ¼ë¡œ í­ë°œ\"). **Corneal Perforation** ìœ„í—˜. | **â˜… IM Ceftriaxone (Systemic!)** + Topical erythromycin prophylaxis fail. |\n| **Day 5-14** | **Chlamydia** (C. trachomatis) | Watery â†’ Mucopurulent. **Pneumonia** ìœ„í—˜ (Nasopharynx ê°ì—¼). | **â˜… Oral Erythromycin (Systemic!)** (Why? To prevent pneumonia). |\n| **Anytime** | **HSV** | Vesicles around eyes, Keratitis. | IV Acyclovir. |\n### 4. Trachoma (Global Blindness) ğŸŒ\n- **Cause:** Chlamydia trachomatis serotypes **A, B, C**. (Leading cause of infectious blindness worldwide).\n- **Pathophysiology (Stages):**\n    1. Repeated Infection (Stage 1).\n    2. **Scarring (Stage 2):** ê²°ë§‰ì— í‰í„°ê°€ ìƒê²¨ ìˆ˜ì¶•í•¨.\n    3. **Entropion:** ëˆˆêº¼í’€ì´ ì•ˆìª½ìœ¼ë¡œ ë§ë ¤ ë“¤ì–´ê°.\n    4. **Trichiasis:** ì†ëˆˆì¹ì´ ê°ë§‰(Cornea)ì„ ì°Œë¦„ (Windshield wiper made of sandpaper).\n    5. **Corneal Opacity:** ì‹¤ëª…(Blindness).\n- **Tx:** Oral Azithromycin (Mass administration).\n---\n### 5. Corneal Ulcers (Keratitis) ğŸ¦ \n**ğŸšª Vignette Anchor:** ëˆˆì´ ì•„í”„ê³ (Pain), ì¶©í˜ˆ(Red), **Photophobia (ëˆˆë¶€ì‹¬)**. ê°ë§‰(Window)ì´ ê³µê²©ë°›ìŒ.\n### A. HSV Keratitis (Herpes)\n- **Stain:** **Dendritic Ulcer** (ë‚˜ë­‡ê°€ì§€ ëª¨ì–‘, Branching lightning bolt).\n- **Sensation:** **Reduced Corneal Sensation** (Cotton wisp test ì‹œ ëˆˆ ì•ˆ ê¹œë¹¡ì„). ë°”ì´ëŸ¬ìŠ¤ê°€ ì‹ ê²½ì„ íŒŒê´´í•¨.\n- **Tx:** Oral/Topical Acyclovir or Ganciclovir. **Avoid Steroids!** (ìŠ¤í…Œë¡œì´ë“œëŠ” ìƒí™©ì„ ì•…í™”ì‹œí‚´).\n### B. Bacterial Keratitis\n- **Vignette:** Contact lens wearer + Red eye + Pain.\n- **Finding:** Round central ulcer, Stromal abscess, Hypopyon possible.\n- **Bug:** Usually **Pseudomonas** (Contact lens).\n- **Tx:** Topical Fluoroquinolones (Hourly dosing).\n### C. Fungal Keratitis","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-41","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"- **Vignette:** **Agricultural worker / Gardener**. ë‚˜ë­‡ê°€ì§€ì— ëˆˆì„ ì°”ë¦¼ (Vegetative matter).\n- **Finding:** **\"Feathery\" borders** (ê¹ƒí„¸ ëª¨ì–‘ ê°€ì¥ìë¦¬), **Satellite lesions** (ì£¼ë³€ì— ìœ„ì„± ë³‘ë³€).\n- **Tx:** Topical Antifungals (Natamycin etc).\n---\n### 6. Endophthalmitis (The Nightmare) ğŸ’€\n- **Definition:** Vitreous Humour (ëˆˆì•Œ ë‚´ë¶€ ì ¤ë¦¬)ì˜ ê°ì—¼. Pus inside the eyeball.\n- **Vignette:** ë°±ë‚´ì¥ ìˆ˜ìˆ (Cataract surgery) í›„ **6ì£¼ ì´ë‚´**. ì‹œë ¥ì´ ì¢‹ì•„ì§€ë‹¤ê°€ ê°‘ìê¸° **ì‹¬í•œ í†µì¦(Severe Pain) + ì‹œë ¥ ì €í•˜(Vision Loss)**.\n- **Key Signs:**\n    - **Hypopyon:** ì „ë°©(Anterior chamber)ì— ê³ ë¦„ì´ ìŒ“ì—¬ì„œ í•˜ì–€ ì´ˆìŠ¹ë‹¬(White crescent) ëª¨ì–‘ì´ ë³´ì„.\n    - **Haze:** Vitreousê°€ ë¿Œì˜‡ê²Œ ë³€í•¨.\n- **Variant:** **Candida Endophthalmitis** (ICU í™˜ì, TPN ì‚¬ìš©, Central line). í†µì¦ì´ ì—†ì„ ìˆ˜ë„ ìˆìŒ(Painless). \"Fungal balls\" (í•˜ì–€ ì†œë­‰ì¹˜) floating.\n- **Tx:** **â˜… Intravitreal Antibiotics + Vitrectomy** (\"Tap and Inject\"). ì•ˆêµ¬ì— ì§ì ‘ ì£¼ì‚¬í•˜ê³ , ê°ì—¼ëœ ì ¤ë¦¬ë¥¼ ê¸°ê³„ë¡œ ë¹¨ì•„ëƒ„.\n---\n### 7. Uveitis (Anterior) ğŸ”¥\n- **Anatomy:** Iris + Ciliary Body inflammation.\n- **Symptoms:** **Deep Aching Pain** + **Photophobia (Extreme)**. ë¹›ì„ ë¹„ì¶”ë©´ í™ì±„ ê·¼ìœ¡ì´ ìˆ˜ì¶•í•˜ë©´ì„œ ì—¼ì¦ ë¶€ìœ„ë¥¼ ì§œë‚´ê¸° ë•Œë¬¸ì— ì—„ì²­ ì•„í””.\n- **Exam Findings:**\n    - **Ciliary Flush:** ê°ë§‰ ì£¼ë³€(Limbus)ì— ë¶‰ì€ ë (Red ring/Sunburst).\n    - **Constricted Pupil (Miosis):** ë™ê³µì´ ì‘ì•„ì§.\n    - **Hypopyon:** ì‹¬í•˜ë©´ ê³ ë¦„ ë³´ì„.\n- **Associations (Systemic):** **HLA-B27** (Ankylosing Spondylitis, IBD, Reactive Arthritis). ì Šì€ ë‚¨ìê°€ í—ˆë¦¬ ì•„í”„ê³  ëˆˆ ì•„í”„ë©´ ì´ê±°!\n- **Tx:** Topical Steroids (ì—¼ì¦ ì™„í™”) + Cycloplegics (ëª¨ì–‘ì²´ ê·¼ìœ¡ ë§ˆë¹„ì‹œì¼œ í†µì¦ ì™„í™”).\n---\n### 8. Lumps & Bumps (Eyelid & Lacrimal) ğŸ”ï¸\n### A. Hordeolum vs. Chalazion\n| **Feature** | **Hordeolum (Stye)** | **Chalazion** |\n| --- | --- | --- |\n| **Nature** | **Infection** (Acute) | **Granuloma** (Chronic) |\n| **Cause** | Staph aureus (Abscess of gland) | Blocked Oil Gland (Meibomian) |\n| **Pain** | **Painful (H for Hurt)** | **Painless (C for Chill)** |\n| **Appearance** | Red, tender bump, pus point | Rubbery, hard nodule |\n| **Tx** | Warm Compress (Drainage) | Warm Compress (Wait it out) |\n### B. Blepharitis\n- **Concept:** \"Dandruff of the eyelashes\" (ì†ëˆˆì¹ ë¹„ë“¬).\n- **Sx:** Scalling, Crusting, Itchy eyelids.\n- **Tx:** Lid Hygiene (Baby shampoo scrubbing), Warm compress.\n### C. Lacrimal System (Plumbing)\n- **Dacryocystitis:**\n    - **Infection** of the Lacrimal Sac.\n    - **Location:** **Medial Canthus** (ëˆˆ ì•ˆìª½ êµ¬ì„/ì½” ì˜†).\n    - **Sx:** ë¹¨ê°›ê³ , ì•„í”„ê³ , ëˆ„ë¥´ë©´ ê³ ë¦„(Pus) ë‚˜ì˜´.\n    - **Tx:** Antibiotics.\n- **Nasolacrimal Duct Stenosis (Congenital):**\n    - **Plumbing Blockage.** ë°°ìˆ˜êµ¬ê°€ ë§‰í˜.\n    - **Sx:** **\"Wet Eye\"** (í•­ìƒ ëˆˆë¬¼ì´ ê³ ì—¬ìˆìŒ). **BUT** ê²°ë§‰ì€ í•˜ì–—ê³  ê¹¨ë—í•¨ (No redness/inflammation).\n    - **Tx:** Lacrimal Sac Massage (ë¶€ëª¨ê°€ ë§ˆì‚¬ì§€í•´ì„œ ëš«ì–´ì¤Œ). ì•ˆ ë˜ë©´ Probing.\n---","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-61","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","treatment"]}
